We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: November 22, 2007
Last Update Posted: November 22, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Ministry of Health, Israel
Information provided by:
Tel-Aviv Sourasky Medical Center
The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.

Infective Endocarditis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Study of Autoantibodies in Infective Endocarditis

Resource links provided by NLM:

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Biospecimen Retention:   None Retained

Estimated Enrollment: 100
Study Start Date: November 2007
Estimated Study Completion Date: November 2008
infective endocarditis patients before treatment
infective endocarditis treatment after treatment


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
infective endocarditis patients

Inclusion Criteria:

  • Infective endocarditis patients by DUKES criteria

Exclusion Criteria:

  • HIV positive
  • Patients suffering from other infective diseases other than endocarditis.
  • Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00562653

Sourasky Medical Center Not yet recruiting
Tel-Aviv, Israel
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Ministry of Health, Israel
Principal Investigator: Victoria Bogusllavsky, MD Sourasky Medical Center, Internal Medicine
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00562653     History of Changes
Other Study ID Numbers: sourasky medical centrs
First Submitted: November 20, 2007
First Posted: November 22, 2007
Last Update Posted: November 22, 2007
Last Verified: November 2007

Keywords provided by Tel-Aviv Sourasky Medical Center:
profile autoantibodies
clinical symptoms

Additional relevant MeSH terms:
Endocarditis, Bacterial
Heart Diseases
Cardiovascular Diseases
Bacterial Infections
Cardiovascular Infections
Immunologic Factors
Physiological Effects of Drugs